Literature DB >> 27602130

Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.

Changyu Zhou1, Jiayu Li2, Jiarui Li3, Yingchun Wan4, Tao Li5, Piyong Ma6, Yingjian Wang7, Haiyan Sang2.   

Abstract

The aim of the present study was to identify the differentially expressed microRNAs (DEMs) between Lynch syndrome (LS) and the normal colonic (N-C) control samples, predict the target genes (TGs) and analyze the potential functions of the DEMs and TGs. The miRNA expression dataset GSE30454, which included data of 13 LS and 20 N-C tissue samples, was downloaded from the Gene Expression Omnibus. The classical t-test in Linear Models for Microarray Data package was used for DEM identification. TG prediction was performed using 5 databases. The regulatory network of the DEMs and their TGs was constructed using Cytoscape. Functional and pathway enrichment analysis was performed. The transcription factors (TFs), tumor-associated genes (TAG) and tumor suppressor genes (TSGs) were then identified. Three key DEMs hsa-miR-137, hsa-miR-520e, and hsa-miR-590-3p were identified. Hsa-miR-520e and hsa-miR-137 had 4 common TGs, including SNF related kinase, metal-regulatory transcription factor 1 (MTF1), round spermatid basic protein 1 and YTH N6-methyladenosine RNA binding protein 3; hsa-miR-590-3p and hsa-miR-137 had 14 common TGs, including NCK adaptor protein 1 (NCK1), EPH receptor A7, and stress-associated endoplasmic reticulum protein 1; hsa-miR-590-3p and hsa-miR-520e had 12 common TGs, including Krüppel-like factor (KLF) 13, twinfilin actin binding protein 1, and nuclear factor I B. Through the functional and pathway enrichments analysis, MTF1 was involved in regulation of gene expression and metabolic processes, and sequence-specific DNA binding TF activity. KLF13 was involved in regulation of gene expression and regulation of cellular metabolic processes. NCK1 was enriched in the axon guidance pathway. In addition, the functional and pathway enrichment analysis showed certain TGs, such as hypoxia-inducible factor 1α, AKT serine/threonine kinase 2, and rapamycin-insensitive companion of mammalian target of rapamycin, participated in the mTOR signaling pathway. The 3 key DEMs hsa-miR-137, hsa-miR-520e, and hsa-miR-590-3p may have important roles in the process of LS.

Entities:  

Keywords:  Lynch syndrome; differentially expressed miRNA; regulatory network; target gene

Year:  2016        PMID: 27602130      PMCID: PMC4998582          DOI: 10.3892/ol.2016.4816

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  49 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  TORward AKTually useful mouse models.

Authors:  Ingo K Mellinghoff; Charles L Sawyers
Journal:  Nat Med       Date:  2004-06       Impact factor: 53.440

3.  Heredity and DNA methylation in colorectal cancer.

Authors:  J R Jass
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

4.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

Review 5.  Polymorphic variants in the p53 pathway.

Authors:  M E Murphy
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

6.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

Authors:  Hemant K Roy; Bola F Olusola; Dahn L Clemens; William J Karolski; Anne Ratashak; Henry T Lynch; Thomas C Smyrk
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

7.  A conserved cysteine cluster, essential for transcriptional activity, mediates homodimerization of human metal-responsive transcription factor-1 (MTF-1).

Authors:  Viola Günther; Alisa M Davis; Oleg Georgiev; Walter Schaffner
Journal:  Biochim Biophys Acta       Date:  2011-10-25

8.  T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer.

Authors:  Luca Morandi; Dario de Biase; Michela Visani; Adriana Monzoni; Annalisa Tosi; Mauro Brulatti; Daniela Turchetti; Paola Baccarini; Giovanni Tallini; Annalisa Pession
Journal:  Int J Colorectal Dis       Date:  2011-11-23       Impact factor: 2.571

9.  The parkin mutant phenotype in the fly is largely rescued by metal-responsive transcription factor (MTF-1).

Authors:  Nidhi Saini; Oleg Georgiev; Walter Schaffner
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

Review 10.  Genetic alterations in pancreatic carcinoma.

Authors:  Gunter Schneider; Roland M Schmid
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401

View more
  4 in total

1.  Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway.

Authors:  Xiaoyang Shi; Weiwei Sheng; Chao Jia; Jingtong Tang; Ming Dong
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

Review 2.  Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.

Authors:  Gergely Buglyó; Jakub Styk; Ondrej Pös; Ádám Csók; Vanda Repiska; Beáta Soltész; Tomas Szemes; Bálint Nagy
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

3.  Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.

Authors:  Yaling Zhai; Yuanyuan Qi; Xiaoqing Long; Yanna Dou; Dong Liu; Genyang Cheng; Jing Xiao; Zhangsuo Liu; Zhanzheng Zhao
Journal:  J Cell Mol Med       Date:  2019-09-26       Impact factor: 5.310

4.  CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.

Authors:  Quan Liang; Qingjuan Yao; GuoYing Hu
Journal:  Open Med (Wars)       Date:  2019-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.